PLAQUEX ORAL

There are many different kinds of Phosphatidylcholines (PC). There are PCs that contain saturated fatty acid chains which will have a detrimental effect on cell membranes and blood vessel walls. And there are PCs that contain one saturated and one unsaturated fatty acid chain, which is not a beneficial form of PC either. Only PC with unsaturated fatty acid chains (linoleic acid) has the benefits described below. It is called polyenylphosphatidylcholine or dilinoleoylphosphatidylcholine, DLPC.

Plaquex Oral contains pure DLPC.

PC is the building block of cell membranes and transport vessels for blood lipids. The action of DLPC in many studies was reflected in an increase of HDL cholesterol and a decrease in LDL cholesterol, VLDL triglycerides as well as reduced ratio of LDL/HDL cholesterol. The main reason being that the transport vessels had an increased capacity for LDL and HDL up take in their cell membranes. The administration of DLPC also results in a decrease in aortic lipid peroxidation products, but also in an increase in glutathione levels in the liver, plasma and aortic tissue. The glutathione-dependent antioxidative capacity in the aortic wall was found to increase markedly after giving DLPC.

Plaquex Oral is indicated for lowering cholesterol levels, triglyceride levels and to improve liver function but also as a additional treatment to Plaquex infusions to prevent re-formation of plaque in the blood vessels after removal.

Plaquex Oral is also used in kidney disease as studies show that it increases creatinine and urea clearance in conjunction with Plaquex infusions.

Studies in patients with Psoriasis and Neurodermitis show that skin manifestations recede faster and stay in remission longer than with placebo.

It can also be used to alleviate constipation and it rejuvenates cell membranes everywhere to improve cellular functions such as uptake of nutrients, hormones and neurotransmitters and elimination of cellular waste.